Share Price and Basic Stock Data
Last Updated: February 3, 2025, 11:35 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
CIL Nova Petrochemicals Ltd, operating in the textiles sector, reported a share price of ₹118 and a market capitalization of ₹320 Cr. The company has experienced a significant decline in revenue, with sales figures dropping to zero from March 2022 onwards, following a peak of ₹82.90 Cr in March 2021. The previous fiscal year, ending March 2023, also reflected no sales revenue, marking a stark contrast to earlier periods such as March 2021 when sales were ₹154.20 Cr. The company’s inability to generate revenue over the last several quarters raises concerns about operational viability and market positioning. Expenses have also plummeted, with the latest financials showing negligible figures, indicating either severe operational cutbacks or a complete halt in business activities. This trend of declining revenue is alarming and suggests the need for strategic reassessment to regain market traction.
Profitability and Efficiency Metrics
The profitability metrics for CIL Nova Petrochemicals Ltd are troubling, with a reported net profit of -₹6.24 Cr for the last fiscal year, reflecting ongoing losses. The operating profit margin (OPM) stood at -0.49 for the trailing twelve months, indicative of operational inefficiencies. The interest coverage ratio (ICR) was recorded at -8.92x, signaling substantial difficulties in covering interest expenses, which typically indicates potential solvency issues. The return on equity (ROE) was a mere 3.68%, while the return on capital employed (ROCE) was 3.35%, both of which are significantly lower than typical sector averages. These figures highlight ongoing challenges in converting sales into profits, raising red flags for potential investors regarding the company’s operational performance and financial health.
Balance Sheet Strength and Financial Ratios
CIL Nova Petrochemicals Ltd’s balance sheet reveals a complex financial situation. The company reported borrowings of ₹94.66 Cr against reserves of ₹61.72 Cr, resulting in a total debt-to-equity ratio of 0.19, which is relatively low compared to industry norms. However, the current ratio was a concerning 0.30, indicating liquidity issues, while the quick ratio stood at 0.25, suggesting challenges in meeting short-term obligations. The book value per share was ₹32.74, and the price-to-book value ratio was 0.94x, which suggests that the market has undervalued the company’s assets. The enterprise value as of March 2024 was ₹98.97 Cr, pointing to a relatively low valuation in light of the company’s operational struggles. Overall, while the balance sheet shows some strength in terms of low leverage, liquidity concerns and negative profitability metrics cast a shadow over financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern for CIL Nova Petrochemicals Ltd remains unclear, with no available data on promoter, FII, DII, or public holdings. This lack of transparency raises concerns about investor confidence and engagement. The absence of institutional backing typically signals caution for potential investors, as it may indicate a lack of belief in the company’s future prospects. The reported financial metrics, including a negative net profit and declining revenues, further exacerbate this uncertainty. Without clear support from major shareholders or institutional investors, the company may struggle to attract new investment or maintain its current market position. The lack of dividend payouts, which stood at 0.00% for the past several years, also reflects a cautious approach to capital distribution, potentially alienating income-focused investors.
Outlook, Risks, and Final Insight
The outlook for CIL Nova Petrochemicals Ltd appears precarious, primarily due to sustained operational losses and zero revenue generation since March 2022. The company’s financial health is under stress, with negative profitability metrics and low liquidity ratios posing significant risks to its ongoing operations. Strategic risks include the inability to revitalize sales and operational efficiency, which could lead to further financial deterioration. On the other hand, potential strengths lie in its low debt levels, which may provide flexibility for restructuring efforts or operational pivots. Going forward, the company must focus on regaining market share and improving profitability to restore investor confidence and stabilize its financial standing. A turnaround strategy that emphasizes operational efficiency and revenue generation will be critical to navigating the challenges ahead.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of CIL Nova Petrochemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IGC Industries Ltd | 10.8 Cr. | 3.11 | 24.8/2.75 | 540 | 12.3 | 0.00 % | 0.19 % | 0.28 % | 10.0 |
| Hindoostan Mills Ltd | 29.2 Cr. | 176 | 234/154 | 235 | 0.00 % | 28.4 % | 29.8 % | 10.0 | |
| Gokak Textiles Ltd | 57.2 Cr. | 88.0 | 228/59.7 | 85.5 | 0.00 % | 0.85 % | % | 10.0 | |
| Globus Power Generation Ltd | 152 Cr. | 15.4 | 23.0/12.3 | 0.82 | 0.00 % | 7.29 % | 7.29 % | 10.0 | |
| GHCL Textiles Ltd | 762 Cr. | 79.6 | 116/65.0 | 14.4 | 153 | 0.63 % | 4.53 % | 3.96 % | 2.00 |
| Industry Average | 1,660.09 Cr | 129.19 | 101.97 | 80.05 | 0.09% | 10.78% | 29.54% | 8.11 |
Quarterly Result
| Metric | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.69 | 56.16 | 82.90 | 58.02 | 79.56 | 77.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 14.57 | 50.48 | 75.59 | 53.69 | 74.58 | 74.42 | 0.09 | 0.14 | 0.67 | 0.10 | 0.04 | 0.50 | 0.39 |
| Operating Profit | -0.88 | 5.68 | 7.31 | 4.33 | 4.98 | 3.43 | -0.09 | -0.14 | -0.67 | -0.10 | -0.04 | -0.50 | -0.39 |
| OPM % | -6.43% | 10.11% | 8.82% | 7.46% | 6.26% | 4.41% | |||||||
| Other Income | 0.36 | 0.26 | 0.65 | 0.54 | 0.57 | 0.42 | 0.88 | -0.24 | -0.09 | -0.59 | -2.86 | -0.98 | 0.23 |
| Interest | 0.59 | 0.67 | 0.56 | 0.67 | 0.76 | 0.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.03 | 1.02 | 1.06 | 1.03 | 1.04 | 1.06 | 0.31 | 0.32 | 0.32 | 0.25 | 0.32 | 0.23 | 0.22 |
| Profit before tax | -2.14 | 4.25 | 6.34 | 3.17 | 3.75 | 2.16 | 0.48 | -0.70 | -1.08 | -0.94 | -3.22 | -1.71 | -0.38 |
| Tax % | 0.00% | 0.47% | 17.35% | 16.72% | 20.00% | 20.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -2.14 | 4.23 | 5.24 | 2.65 | 3.01 | 1.71 | 0.47 | -0.70 | -1.08 | -0.93 | -3.21 | -1.71 | -0.39 |
| EPS in Rs | -0.79 | 1.56 | 1.93 | 0.98 | 1.11 | 0.63 | 0.17 | -0.26 | -0.40 | -0.34 | -1.18 | -0.63 | -0.14 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for CIL Nova Petrochemicals Ltd based on the most recent figures (Sep 2023) and their trends compared to the previous period:
- For Sales, as of Sep 2023, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 0.00 Cr..
- For Expenses, as of Sep 2023, the value is 0.39 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.50 Cr. (Jun 2023) to 0.39 Cr., marking a decrease of 0.11 Cr..
- For Operating Profit, as of Sep 2023, the value is -0.39 Cr.. The value appears strong and on an upward trend. It has increased from -0.50 Cr. (Jun 2023) to -0.39 Cr., marking an increase of 0.11 Cr..
- For OPM %, as of Sep 2023, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 0.00%.
- For Other Income, as of Sep 2023, the value is 0.23 Cr.. The value appears strong and on an upward trend. It has increased from -0.98 Cr. (Jun 2023) to 0.23 Cr., marking an increase of 1.21 Cr..
- For Interest, as of Sep 2023, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2023, the value is 0.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Jun 2023) to 0.22 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Sep 2023, the value is -0.38 Cr.. The value appears strong and on an upward trend. It has increased from -1.71 Cr. (Jun 2023) to -0.38 Cr., marking an increase of 1.33 Cr..
- For Tax %, as of Sep 2023, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 0.00%.
- For Net Profit, as of Sep 2023, the value is -0.39 Cr.. The value appears strong and on an upward trend. It has increased from -1.71 Cr. (Jun 2023) to -0.39 Cr., marking an increase of 1.32 Cr..
- For EPS in Rs, as of Sep 2023, the value is -0.14. The value appears strong and on an upward trend. It has increased from -0.63 (Jun 2023) to -0.14, marking an increase of 0.49.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
| Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 321.01 | 296.14 | 316.97 | 243.02 | 200.26 | 221.68 | 243.66 | 248.97 | 196.29 | 154.20 | 0.00 | 0.00 | 0.00 |
| Expenses | 301.11 | 277.55 | 299.96 | 225.86 | 183.10 | 207.46 | 235.27 | 243.72 | 193.66 | 142.59 | 0.37 | 0.30 | 1.03 |
| Operating Profit | 19.90 | 18.59 | 17.01 | 17.16 | 17.16 | 14.22 | 8.39 | 5.25 | 2.63 | 11.61 | -0.37 | -0.30 | -1.03 |
| OPM % | 6.20% | 6.28% | 5.37% | 7.06% | 8.57% | 6.41% | 3.44% | 2.11% | 1.34% | 7.53% | |||
| Other Income | 2.62 | 0.74 | 0.98 | 0.36 | 0.40 | 1.36 | 2.31 | 1.88 | 2.36 | 1.50 | 9.46 | -4.38 | -4.20 |
| Interest | 9.17 | 8.03 | 6.96 | 5.82 | 3.76 | 3.26 | 3.92 | 3.72 | 3.79 | 2.54 | 0.00 | 0.00 | 0.00 |
| Depreciation | 8.57 | 7.82 | 7.16 | 6.62 | 5.89 | 5.39 | 5.15 | 4.65 | 4.24 | 4.12 | 1.25 | 1.25 | 1.02 |
| Profit before tax | 4.78 | 3.48 | 3.87 | 5.08 | 7.91 | 6.93 | 1.63 | -1.24 | -3.04 | 6.45 | 7.84 | -5.93 | -6.25 |
| Tax % | 1.05% | 20.69% | 25.06% | 21.06% | 30.72% | 28.14% | 22.09% | -1.61% | 0.00% | 17.36% | 0.00% | 0.00% | |
| Net Profit | 4.73 | 2.77 | 2.90 | 4.02 | 5.48 | 4.98 | 1.27 | -1.26 | -3.05 | 5.33 | 7.84 | -5.93 | -6.24 |
| EPS in Rs | 1.75 | 1.02 | 1.07 | 1.48 | 2.02 | 1.84 | 0.47 | -0.46 | -1.13 | 1.97 | 2.89 | -2.19 | -2.29 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -41.44% | 4.69% | 38.62% | 36.32% | -9.12% | -74.50% | -199.21% | -142.06% | 274.75% | 47.09% | -175.64% |
| Change in YoY Net Profit Growth (%) | 0.00% | 46.13% | 33.93% | -2.30% | -45.44% | -65.37% | -124.71% | 57.15% | 416.82% | -227.66% | -222.73% |
CIL Nova Petrochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: November 15, 2024, 1:31 am
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13.55 | 13.55 | 13.55 | 13.55 | 27.10 | 27.10 | 27.10 | 27.10 | 27.10 | 27.10 | 27.10 | 27.10 | 27.10 |
| Reserves | 32.53 | 35.43 | 39.31 | 44.79 | 55.84 | 57.17 | 55.94 | 52.98 | 58.36 | 66.25 | 60.81 | 61.64 | 61.72 |
| Borrowings | 100.39 | 89.15 | 62.33 | 37.26 | 24.61 | 19.36 | 24.14 | 19.56 | 19.60 | 26.76 | 0.22 | 17.58 | 94.66 |
| Other Liabilities | 28.40 | 51.02 | 42.99 | 55.91 | 53.59 | 57.36 | 60.00 | 51.45 | 60.00 | 35.60 | 2.59 | 5.51 | 7.32 |
| Total Liabilities | 174.87 | 189.15 | 158.18 | 151.51 | 161.14 | 160.99 | 167.18 | 151.09 | 165.06 | 155.71 | 90.72 | 111.83 | 190.80 |
| Fixed Assets | 104.54 | 99.06 | 93.51 | 90.12 | 89.53 | 86.29 | 81.50 | 83.73 | 83.77 | 82.62 | 58.32 | 61.36 | 60.38 |
| CWIP | 4.83 | 4.82 | 4.82 | 4.82 | 4.82 | 8.74 | 9.04 | 3.68 | 3.68 | 3.68 | 0.04 | 25.46 | 52.65 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 65.50 | 85.27 | 59.85 | 56.57 | 66.79 | 65.96 | 76.64 | 63.68 | 77.61 | 69.41 | 32.36 | 25.01 | 77.77 |
| Total Assets | 174.87 | 189.15 | 158.18 | 151.51 | 161.14 | 160.99 | 167.18 | 151.09 | 165.06 | 155.71 | 90.72 | 111.83 | 190.80 |
Below is a detailed analysis of the balance sheet data for CIL Nova Petrochemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is 27.10 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.10 Cr..
- For Reserves, as of Sep 2024, the value is 61.72 Cr.. The value appears strong and on an upward trend. It has increased from 61.64 Cr. (Mar 2024) to 61.72 Cr., marking an increase of 0.08 Cr..
- For Borrowings, as of Sep 2024, the value is 94.66 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 17.58 Cr. (Mar 2024) to 94.66 Cr., marking an increase of 77.08 Cr..
- For Other Liabilities, as of Sep 2024, the value is 7.32 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.51 Cr. (Mar 2024) to 7.32 Cr., marking an increase of 1.81 Cr..
- For Total Liabilities, as of Sep 2024, the value is 190.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 111.83 Cr. (Mar 2024) to 190.80 Cr., marking an increase of 78.97 Cr..
- For Fixed Assets, as of Sep 2024, the value is 60.38 Cr.. The value appears to be declining and may need further review. It has decreased from 61.36 Cr. (Mar 2024) to 60.38 Cr., marking a decrease of 0.98 Cr..
- For CWIP, as of Sep 2024, the value is 52.65 Cr.. The value appears strong and on an upward trend. It has increased from 25.46 Cr. (Mar 2024) to 52.65 Cr., marking an increase of 27.19 Cr..
- For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2024, the value is 77.77 Cr.. The value appears strong and on an upward trend. It has increased from 25.01 Cr. (Mar 2024) to 77.77 Cr., marking an increase of 52.76 Cr..
- For Total Assets, as of Sep 2024, the value is 190.80 Cr.. The value appears strong and on an upward trend. It has increased from 111.83 Cr. (Mar 2024) to 190.80 Cr., marking an increase of 78.97 Cr..
However, the Borrowings (94.66 Cr.) are higher than the Reserves (61.72 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 19.90 | -81.80 | -72.14 | -45.17 | -20.10 | -10.39 | -10.97 | -18.89 | -16.93 | -7.99 | -27.13 | -0.52 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
No data available for the Financial Efficiency data table.
No data available for the Shareholding
No data available for the Shareholding Pattern chart.
No data available for the No. of Shareholders chart.
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.30 | -2.19 | 2.89 | 1.97 | -1.12 |
| Diluted EPS (Rs.) | 0.30 | -2.19 | 2.89 | 1.97 | -1.12 |
| Cash EPS (Rs.) | 1.01 | -0.59 | 4.46 | 3.49 | 0.44 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 32.74 | 32.44 | 34.45 | 31.53 | 29.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 32.74 | 32.44 | 34.45 | 31.53 | 29.55 |
| Revenue From Operations / Share (Rs.) | 0.00 | 37.57 | 109.28 | 56.90 | 72.43 |
| PBDIT / Share (Rs.) | -0.49 | 0.05 | 6.04 | 4.84 | 1.84 |
| PBIT / Share (Rs.) | -1.20 | -1.53 | 4.47 | 3.32 | 0.27 |
| PBT / Share (Rs.) | -1.26 | -2.18 | 3.50 | 2.38 | -1.12 |
| Net Profit / Share (Rs.) | 0.30 | -2.19 | 2.89 | 1.97 | -1.12 |
| PBDIT Margin (%) | 0.00 | 0.15 | 5.53 | 8.50 | 2.54 |
| PBIT Margin (%) | 0.00 | -4.07 | 4.09 | 5.83 | 0.37 |
| PBT Margin (%) | 0.00 | -5.79 | 3.20 | 4.18 | -1.55 |
| Net Profit Margin (%) | 0.00 | -5.82 | 2.64 | 3.45 | -1.55 |
| Return on Networth / Equity (%) | 0.91 | -6.74 | 8.39 | 6.23 | -3.80 |
| Return on Capital Employeed (%) | -3.66 | -4.71 | 11.46 | 9.30 | 0.81 |
| Return On Assets (%) | 0.72 | -6.53 | 5.03 | 3.22 | -2.01 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.19 | 0.00 | 0.28 | 0.22 | 0.24 |
| Asset Turnover Ratio (%) | 0.00 | 0.82 | 1.85 | 0.97 | 1.23 |
| Current Ratio (X) | 0.30 | 11.17 | 1.35 | 1.09 | 1.04 |
| Quick Ratio (X) | 0.25 | 10.39 | 0.68 | 0.64 | 0.68 |
| Inventory Turnover Ratio (X) | 0.00 | 2.76 | 5.98 | 3.35 | 6.04 |
| Interest Coverage Ratio (X) | -8.92 | 0.09 | 6.24 | 5.16 | 1.32 |
| Interest Coverage Ratio (Post Tax) (X) | -20.61 | -2.40 | 3.98 | 3.10 | 0.19 |
| Enterprise Value (Cr.) | 98.97 | 49.15 | 138.91 | 61.70 | 28.59 |
| EV / Net Operating Revenue (X) | 0.00 | 0.48 | 0.46 | 0.40 | 0.14 |
| EV / EBITDA (X) | -73.91 | 309.91 | 8.48 | 4.71 | 5.73 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.48 | 0.38 | 0.28 | 0.05 |
| Price / BV (X) | 0.94 | 0.55 | 1.22 | 0.50 | 0.13 |
| Price / Net Operating Revenue (X) | 0.00 | 0.48 | 0.38 | 0.28 | 0.05 |
| EarningsYield | 0.01 | -0.12 | 0.06 | 0.12 | -0.28 |
After reviewing the key financial ratios for CIL Nova Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 5. It has increased from -2.19 (Mar 23) to 0.30, marking an increase of 2.49.
- For Diluted EPS (Rs.), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 5. It has increased from -2.19 (Mar 23) to 0.30, marking an increase of 2.49.
- For Cash EPS (Rs.), as of Mar 24, the value is 1.01. This value is below the healthy minimum of 3. It has increased from -0.59 (Mar 23) to 1.01, marking an increase of 1.60.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 32.74. It has increased from 32.44 (Mar 23) to 32.74, marking an increase of 0.30.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 32.74. It has increased from 32.44 (Mar 23) to 32.74, marking an increase of 0.30.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 0.00. It has decreased from 37.57 (Mar 23) to 0.00, marking a decrease of 37.57.
- For PBDIT / Share (Rs.), as of Mar 24, the value is -0.49. This value is below the healthy minimum of 2. It has decreased from 0.05 (Mar 23) to -0.49, marking a decrease of 0.54.
- For PBIT / Share (Rs.), as of Mar 24, the value is -1.20. This value is below the healthy minimum of 0. It has increased from -1.53 (Mar 23) to -1.20, marking an increase of 0.33.
- For PBT / Share (Rs.), as of Mar 24, the value is -1.26. This value is below the healthy minimum of 0. It has increased from -2.18 (Mar 23) to -1.26, marking an increase of 0.92.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 2. It has increased from -2.19 (Mar 23) to 0.30, marking an increase of 2.49.
- For PBDIT Margin (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 10. It has decreased from 0.15 (Mar 23) to 0.00, marking a decrease of 0.15.
- For PBIT Margin (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -4.07 (Mar 23) to 0.00, marking an increase of 4.07.
- For PBT Margin (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -5.79 (Mar 23) to 0.00, marking an increase of 5.79.
- For Net Profit Margin (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -5.82 (Mar 23) to 0.00, marking an increase of 5.82.
- For Return on Networth / Equity (%), as of Mar 24, the value is 0.91. This value is below the healthy minimum of 15. It has increased from -6.74 (Mar 23) to 0.91, marking an increase of 7.65.
- For Return on Capital Employeed (%), as of Mar 24, the value is -3.66. This value is below the healthy minimum of 10. It has increased from -4.71 (Mar 23) to -3.66, marking an increase of 1.05.
- For Return On Assets (%), as of Mar 24, the value is 0.72. This value is below the healthy minimum of 5. It has increased from -6.53 (Mar 23) to 0.72, marking an increase of 7.25.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.19. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 0.19, marking an increase of 0.19.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.00. It has decreased from 0.82 (Mar 23) to 0.00, marking a decrease of 0.82.
- For Current Ratio (X), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 1.5. It has decreased from 11.17 (Mar 23) to 0.30, marking a decrease of 10.87.
- For Quick Ratio (X), as of Mar 24, the value is 0.25. This value is below the healthy minimum of 1. It has decreased from 10.39 (Mar 23) to 0.25, marking a decrease of 10.14.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 2.76 (Mar 23) to 0.00, marking a decrease of 2.76.
- For Interest Coverage Ratio (X), as of Mar 24, the value is -8.92. This value is below the healthy minimum of 3. It has decreased from 0.09 (Mar 23) to -8.92, marking a decrease of 9.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -20.61. This value is below the healthy minimum of 3. It has decreased from -2.40 (Mar 23) to -20.61, marking a decrease of 18.21.
- For Enterprise Value (Cr.), as of Mar 24, the value is 98.97. It has increased from 49.15 (Mar 23) to 98.97, marking an increase of 49.82.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 23) to 0.00, marking a decrease of 0.48.
- For EV / EBITDA (X), as of Mar 24, the value is -73.91. This value is below the healthy minimum of 5. It has decreased from 309.91 (Mar 23) to -73.91, marking a decrease of 383.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 23) to 0.00, marking a decrease of 0.48.
- For Price / BV (X), as of Mar 24, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 23) to 0.94, marking an increase of 0.39.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 23) to 0.00, marking a decrease of 0.48.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.12 (Mar 23) to 0.01, marking an increase of 0.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CIL Nova Petrochemicals Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -3.66% (Industry Average ROCE: 10.78%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.91% (Industry Average ROE: 29.54%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -20.61
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.25
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 101.97)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Industry not found | Address not found | Contact not found |
FAQ
What is the intrinsic value of CIL Nova Petrochemicals Ltd?
CIL Nova Petrochemicals Ltd's intrinsic value (as of 21 July 2025) is 14.77 87.48% lower the current market price of 118.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 320 Cr. market cap, FY2025-2026 high/low of 129/25.7, reserves of 61.72 Cr, and liabilities of 190.80 Cr.
What is the Market Cap of CIL Nova Petrochemicals Ltd?
The Market Cap of CIL Nova Petrochemicals Ltd is 320 Cr..
What is the current Stock Price of CIL Nova Petrochemicals Ltd as on 21 July 2025?
The current stock price of CIL Nova Petrochemicals Ltd as on 21 July 2025 is 118.
What is the High / Low of CIL Nova Petrochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CIL Nova Petrochemicals Ltd stocks is ₹129/25.7.
What is the Stock P/E of CIL Nova Petrochemicals Ltd?
The Stock P/E of CIL Nova Petrochemicals Ltd is .
What is the Book Value of CIL Nova Petrochemicals Ltd?
The Book Value of CIL Nova Petrochemicals Ltd is 32.8.
What is the Dividend Yield of CIL Nova Petrochemicals Ltd?
The Dividend Yield of CIL Nova Petrochemicals Ltd is 0.00 %.
What is the ROCE of CIL Nova Petrochemicals Ltd?
The ROCE of CIL Nova Petrochemicals Ltd is 3.35 %.
What is the ROE of CIL Nova Petrochemicals Ltd?
The ROE of CIL Nova Petrochemicals Ltd is 3.68 %.
What is the Face Value of CIL Nova Petrochemicals Ltd?
The Face Value of CIL Nova Petrochemicals Ltd is 10.0.